Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Workday
WDAY
|
+$536M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$466M |
| 3 |
Applovin
APP
|
+$375M |
| 4 |
PNC Financial Services
PNC
|
+$316M |
| 5 |
Blackstone
BX
|
+$306M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$889M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$535M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$485M |
| 4 |
American Tower
AMT
|
+$378M |
| 5 |
UnitedHealth
UNH
|
+$371M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.18% |
| 2 | Healthcare | 15.93% |
| 3 | Financials | 10.17% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAZE
626
Maze Therapeutics
MAZE
$1.51B
| $19.5M | 0.01% |
751,874
-649,386
| -46% | -$11M |
|
627
HF Sinclair
DINO
$16.2B
| $19.5M | 0.01% |
371,743
-114,784
| -24% | -$5.44M |
|
|
FOLD
628
DELISTED
Amicus Therapeutics
FOLD
| $19.4M | 0.01% |
2,466,021
-287,689
| -10% | -$2.05M |
|
629
Tango Therapeutics
TNGX
$4.21B
| $19.3M | 0.01% |
+2,302,274
| New | +$15.6M |
|
630
Apogee Therapeutics
APGE
$10.1B
| $19.3M | 0.01% |
485,978
-23,343
| -5% | -$891K |
|
631
Assembly Biosciences
ASMB
$498M
| $19.2M | 0.01% |
+752,626
| New | +$16.5M |
|
632
California Resources
CRC
$4.49B
| $19.2M | 0.01% |
360,874
+48
| +0% | +$2.4K |
|
633
Ingredion
INGR
$6.42B
| $19.1M | 0.01% |
156,603
+52,081
| +50% | +$6.71M |
|
634
Howard Hughes
HHH
$3.94B
| $18.9M | 0.01% |
230,146
+215,374
| +1,458% | +$15.9M |
|
635
AppFolio
APPF
$6.62B
| $18.9M | 0.01% |
68,555
-63,275
| -48% | -$17.1M |
|
636
Box
BOX
$4.49B
| $18.9M | 0.01% |
584,623
+107,049
| +22% | +$3.47M |
|
637
Novanta
NOVT
$4.91B
| $18.8M | 0.01% |
187,486
-4,611
| -2% | -$549K |
|
638
AAR Corp
AIR
$5.4B
| $18.7M | 0.01% |
208,459
-85,482
| -29% | -$6.51M |
|
639
Protara Therapeutics
TARA
$214M
| $18.4M | 0.01% |
4,231,331
+128,711
| +3% | +$417K |
|
640
Trade Desk
TTD
$8.97B
| $18.3M | 0.01% |
373,896
+342,116
| +1,077% | +$21.7M |
|
641
McCormick & Company Non-Voting
MKC
$14B
| $18.2M | 0.01% |
272,245
-5,303
| -2% | -$371K |
|
642
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.2B
| $18.1M | 0.01% |
214,918
-2,622
| -1% | -$218K |
|
643
Royal Bank of Canada
RY
$287B
| $18M | 0.01% |
121,893
-928
| -0.8% | -$128K |
|
|
ALE
644
DELISTED
Allete
ALE
| $17.9M | 0.01% |
269,585
| – | – |
|
645
Wolverine World Wide
WWW
$1.68B
| $17.9M | 0.01% |
651,214
+298,398
| +85% | +$7.85M |
|
646
StoneX
SNEX
$8.72B
| $17.7M | 0.01% |
395,417
-20,374
| -5% | -$865K |
|
647
Moelis & Co
MC
$4.85B
| $17.5M | 0.01% |
245,380
+214,654
| +699% | +$15.3M |
|
648
Arrow Electronics
ARW
$10.5B
| $17.4M | 0.01% |
143,412
+276
| +0.2% | +$34.7K |
|
|
AVDX
649
DELISTED
AvidXchange
AVDX
| $17.2M | 0.01% |
1,728,785
| – | – |
|
650
Centrus Energy
LEU
$3.14B
| $17.2M | 0.01% |
55,314
+13,328
| +32% | +$2.95M |
|
Similar funds
Janus Henderson Group's Q3 2025 Portfolio in Review
As of Q3 2025, Janus Henderson Group held 2,484 positions worth $219B, up 7.4% from $204B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Janus Henderson Group's Q3 2025 filing shows 84 new, 672 increased, 650 reduced and 88 closed positions. Its largest new stake was Janus Henderson Asset-Backed Securities ETF: 2,575,000 shares worth $130M. The largest sale was Marvell Technology, an estimated $889M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2025 buy was Janus Henderson Asset-Backed Securities ETF: 2,575,000 shares worth $130M.
- Janus Henderson Group added most to Workday in Q3 2025, an estimated $536M increase.
- Janus Henderson Group's biggest Q3 2025 reduction was Marvell Technology, cutting an estimated $889M.
- Janus Henderson Group fully exited Alibaba in Q3 2025, selling an estimated $96.4M.
- Janus Henderson Group's ten largest holdings make up 34% of its $219B portfolio in Q3 2025.
- Janus Henderson Group opened 84 new positions and closed 88 in Q3 2025.
- Janus Henderson Group's portfolio value rose 7.4% quarter-over-quarter to $219B.
Based on Janus Henderson Group's 13F filing for Q3 2025, filed 14 Nov 2025.